Fondaparinux Sodium
Who holds supplier records for Fondaparinux Sodium? 11 organisations hold a current record for Fondaparinux Sodium: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: China (4), India (2), Taiwan (2) and Netherlands (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Fondaparinux Sodium: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/fondaparinux-sodium
Reading the evidence
- 11 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (11)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Fondaparinux Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.
- BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTDChinaActive DMF 37729, 30767 · latest filing Dec 2022
- HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTDChinaActive DMF 34828, 28584 · latest filing Apr 2020
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 27873 · latest filing Jan 2014
- ASPEN OSS BVNetherlands Company GMP cert on recordActive DMF 28762 · latest filing Nov 2014
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 22579 · latest filing Feb 2009
- Formosa Laboratories, Inc.Taiwan Company GMP cert on recordActive DMF 27475 · latest filing Sept 2013
- JIANGSU HENGRUI PHARMACEUTICALS CO LTDChina Company GMP cert on recordActive DMF 27336 · latest filing Sept 2013
- NEWLAND PHARMACEUTICAL CO LTDActive DMF 41883 · latest filing May 2025
- SCINOPHARM TAIWAN LTDTaiwanActive DMF 27563 · latest filing Dec 2013
- SICHUAN AUPONE PHARMACEUTICAL CO LTDActive DMF 38428 · latest filing Jun 2023
- Wisdom Pharmaceutical Co., LtdChinaActive DMF 37499 · latest filing Oct 2022
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (4)
Organisations whose Type II DMFs for Fondaparinux Sodium are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- United States · Inactive DMF 25093 · filed Jun 2011
- MYLAN LABORATORIES LTDInactive DMF 23863 · filed Jun 2010
- France · Inactive DMF 15259 · filed Jan 2001
- GLAXO GROUP LTD DBA GLAXOSMITHKLINEInactive DMF 15257 · filed Jan 2001
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Fondaparinux Sodium is a oligosaccharide active pharmaceutical ingredient (ChEMBL CHEMBL1200644).
Chemical identity
- IUPAC name
- decasodium;(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-5-sulfonatooxyoxan-3-yl]oxy-5-(sulfonatoamino)-4-sulfonatooxy-2-(sulfonatooxymethyl)oxan-3-yl]oxy-3-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)oxan-2-yl]oxy-4,5-dihydroxyoxane-2-carboxylate
- Canonical SMILES
- CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
- InChIKey
- XEKSTYNIJLDDAZ-JASSWCPGSA-D
- Synonyms
- Arixtra, Fondaparin sodium, Fondaparinux sodico, Fondaparinux sodique, Fondaparinux sodium, Fondaparinux sodium for assay, Fondaparinux sodium identification, IC-851589, ORG 31540, ORG-31540, Quixidar, SR 90107A
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Factor Xa Inhibitor
- Mechanism of action
- Factor Xa Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Fondaparinux Sodium?
11 organisations hold an active US FDA Type II Drug Master File or a CEP for Fondaparinux Sodium: BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD (China), HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD (China), APITORIA PHARMA PRIVATE LTD (India), ASPEN OSS BV (Netherlands), Dr. Reddy's Laboratories Ltd. (India), Formosa Laboratories, Inc. (Taiwan), JIANGSU HENGRUI PHARMACEUTICALS CO LTD (China) and NEWLAND PHARMACEUTICAL CO LTD, and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Fondaparinux Sodium Drug Master Files are active?
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD (DMF 37729, 30767), HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD (DMF 34828, 28584), APITORIA PHARMA PRIVATE LTD (DMF 27873), ASPEN OSS BV (DMF 28762), Dr. Reddy's Laboratories Ltd. (DMF 22579), Formosa Laboratories, Inc. (DMF 27475), JIANGSU HENGRUI PHARMACEUTICALS CO LTD (DMF 27336) and NEWLAND PHARMACEUTICAL CO LTD (DMF 41883) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Fondaparinux Sodium records mean?
4 organisations have only inactive Type II DMFs for Fondaparinux Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Fondaparinux Sodium supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Fondaparinux Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.